Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 4, 2006, Pages 1595-1599

  Grottoli, S ^a   Gasco, V ^a   Broglio, F ^a   Baldelli, R ^a   Ragazzoni, F ^a   Gallenca, F ^a   Mainolfi, A ^a   Prodam, F ^a   Muccioli, G ^b   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTISTATIN; GROWTH HORMONE; INSULIN; NEUROPEPTIDE; PROLACTIN; SODIUM CHLORIDE; SOMATOSTATIN 14; UNCLASSIFIED DRUG; CARRIER PROTEIN; CORT PROTEIN, HUMAN; GLUCOSE OXIDASE; HUMAN GROWTH HORMONE; SOMATOSTATIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GROWTH HORMONE RELEASE; HUMAN; INSULIN RELEASE; MALE; PRIORITY JOURNAL; PROLACTIN RELEASE; PROLACTINOMA; AREA UNDER THE CURVE; BLOOD; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

ACROMEGALY; ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; BODY MASS INDEX; CARRIER PROTEINS; FEMALE; GLUCOSE OXIDASE; HUMAN GROWTH HORMONE; HUMANS; INSULIN; MALE; MIDDLE AGED; NEUROPEPTIDES; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; SOMATOSTATIN;

EID: 33646042271     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1837     Document Type: Article

References (20)

1. Patel YC 1999 Somatostatin and its receptor family. Front Neuroendocrinol 20:157-198
2. de Lecea L, Criado JR, Prospero-Garcia O, Gautvik KM, Schweitzer P, Danielson PE, Dunlop CL, Siggins GR, Henriksen SJ, Sutcliffe JG 1996 A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature 381:242-245
3. Spier AD, de Lecea L 2000 Cortistatin: a member of the somatostatin neuropeptide family with distinct physiological functions. Brain Res Brain Res Rev 33:228-241
4. Dalm VA, Van Hagen PM, de Krijger RR, Kros JM, Van Koetsveld PM, Van Der Lely AJ, Lamberts SW, Hofland LJ 2004 Distribution pattern of somatostatin and cortistatin mRNA in human central and peripheral tissues. Clin Endocrinol (Oxf) 60:625-629
5. Papotti M, Tarabra E, Allia E, Bozzalla-Cassione F, Broglio F, Deghenghi R, Ghigo E, Muccioli G 2003 Presence of cortistatin in the human pancreas. J Endocrinol Invest 26:RC15-RC18
6. Calbet M, Guadano-Ferraz A, Spier AD, Maj M, Sutcliffe JG, Przewlocki R, de Lecea L 1999 Cortistatin and somatostatin mRNAs are differentially regulated in response to kainate. Brain Res Mol Brain Res 72:55-64
7. Robas N, Mead E, Fidock M 2003 MrgX2 is a high potency cortistatin receptor expressed in dorsal root ganglion. J Biol Chem 278:44400-44404
8. Deghenghi R, Papotti M, Ghigo E, Muccioli G 2001 Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland. J Endocrinol Invest 24:RC1-RC3
9. van der Lely AJ, Tschop M, Heiman ML, Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457
10. Broglio F, Arvat E, Benso A, Gottero C, Prodam F, Grottoli S, Papotti M, Muccioli G, van der Lely AJ, Deghenghi R, Ghigo E 2002 Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 87:3783-3790
11. Gottero C, Prodam F, Destefanis S, Benso A, Gauna C, Me E, Filtri L, Riganti F, van Der Lely AJ, Ghigo E, Broglio F 2004 Cortistatin-17 and -14 exert the same endocrine activities as somatostatin in humans. Growth Horm IGF Res 14:382-387
12. Kim K, Arai K, Sanno N, Teramoto A, Shibasaki T 2001 The expression of thyrotrophin releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas. Clin Endocrinol (Oxf) 54:309-316
13. Lania A, Mantovani G, Ferrante E, Zavanone LM, Locatelli M, Corbetta S, Beck-Peccoz P, Spada A 2004 Gonadotropin-releasing hormone initiates multiple signaling pathways in human GH-secreting adenomas. J Endocrinol Invest 27:328-333
14. Arosio M, Ronchi CL, Gebbia C, Pizzinelli S, Conte D, Cappiello V, Epaminonda P, Cesana BM, Beck-Peccoz P, Peracchi M 2004 Ghrelin administration affects circulating pituitary and gastro-entero-pancreatic hormones in acromegaly. Eur J Endocrinol 150:27-32
15. Jaquet P, Ouafik L, Saveanu A, Gunz G, Fina F, Dufour H, Culler MD, Moreau JP, Enjalbert A 1999 Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas. J Clin Endocrinol Metab 84:3268-3276
16. Jaquet P, Saveanu A, Gunz G, Fina F, Zamora AJ, Grino M, Culler MD, Moreau JP, Enjalbert A, Ouafik LH 2000 Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes. J Clin Endocrinol Metab 85:781-792
17. Lamberts SW, Zweens M, Klijn JG, van Vroonhoven CC, Stefanko SZ, Del Pozo E 1986 The sensitivity of growth hormone and prolactin secretion to the somatostatin analogue SMS 201-995 in patients with prolactinomas and acromegaly. Clin Endocrinol (Oxf) 25:201-212
18. Bronstein MD, Knoepfelmacher M, Liberman B, Marino Jr R, Germek OA, Schally AV 1987 Absence of suppressive effect of somatostatin on prolactin levels in patients with hyperprolactinemia. Horm Metab Res 19:271-274
19. Tuzcu A, Bahceci M, Dursun M, Turgut C, Bahceci S 2003 Insulin sensitivity and hyperprolactinemia. J Endocrinol Invest 26:341-346
20. Baldelli R, Battista C, Leonetti F, Ghiggi MR, Ribaudo MC, Paoloni A, D'Amico E, Ferretti E, Baratta R, Liuzzi A, Trischitta V, Tamburrano G 2003 Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment. Clin Endocrinol (Oxf) 59:492-499